All lobbying filings

Venn Strategies

Venn Strategies filed a Q3 report for Pacira Pharmaceuticals Inc. on October 20, 2026, reporting $90,000 in lobbying income.

Lobbying for Pacira Pharmaceuticals Inc. · Pharmaceutical company

As filed: VENN STRATEGIES for PACIRA PHARMACEUTICALS INC.

All filings by Venn Strategies · Everything Pacira Pharmaceuticals Inc. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

New Jersey

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Improving access to non-opioid approaches to pain management.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem